跳至主要内容
临床试验/NL-OMON53992
NL-OMON53992招募中不适用

Coronary Physiology Peri-Transcatheter Left-sided Valvular interventions in Patients with Severe Aortic Stenosis or Mitral Regurgitation - POTUS

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Age >= 18.
  • 2. a. TAVI Cohort: severe aortic valve stenosis for which TAVI is scheduled
  • after discussion in the Heart Team.
  • b. TVMR Cohort: severe functional mitral regurgitation for which TVMR
  • is scheduled after discussion in the Heart Team.
  • 3. At least intermediate coronary artery disease, defined as 50 - 99% DS in a
  • vessel >=2.5 mm.
  • 4. Elective procedure.
  • 5. Written informed consent.

排除标准

  • 1. TAVI cohort: height coronary ostia < 10 mm.
  • 2. Severe chronic kindey disease, defined as estimated glomerular filtration
  • rate < 30 ml/min.
  • 3. Contra-indication for intravenous adenosine (severe asthma or chronic
  • obstructive pulmonary disease, known allergy to adenosine or precious reported
  • bronchospasm in response to adenosine).
  • 4. Degenerated surgical or transcatheter aortic valve bioprosthesis.
  • 5. Vessels that have collaterals to a chronic total occlusion or that are
  • supplied by an arterial or venous bypass graft will not be interrogated in this

研究者

相似试验